Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Small-volume electrolyte-glucose injection to prevent dizziness after painless gastroenteroscopy
ChiCTR2300071243Phase 4Not yet recruiting
- Sponsor
- Jianyang People's Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium + potassium + magnesium + calcium + glucose in dizziness (2 arms), sponsored by Jianyang People's Hospital. Primary endpoint: Incidence of moderate to severe dizziness. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
sodium + potassium + magnesium + calcium + glucose
03
Conditions
dizziness
Beyond the preview
Go deeper on ChiCTR2300071243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300071243.